| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/06/2006 | US20060074255 3-Methyl-20-epi-vitamin D derivatives |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074114 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids |
| 04/06/2006 | US20060074111 Chemical compounds |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2006 | US20060074107 Pharmaceutically active piperidine derivatives |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060074013 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 04/06/2006 | US20060074012 Treatment of gestational diabetes |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073223 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004048388A1 D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung D-pyranosyl-substituted phenyls, medicaments containing these compounds, their use and process for their preparation |
| 04/06/2006 | DE102004042441A1 Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel With amino acids substituted hexahydro-pyrazino (1,2-a) pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments |
| 04/06/2006 | CA2848573A1 Rnai modulation of apob and uses thereof |
| 04/06/2006 | CA2585592A1 Modified coffee, method of roasting coffee bean, coffee-like supplement and auxiliary food |
| 04/06/2006 | CA2581922A1 1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 04/06/2006 | CA2580926A1 Compositions for anti-obesity, health-restorative and health-promotional benefits |
| 04/05/2006 | EP1642983A1 Arachidonic acid and methods for the production and use thereof |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642903A1 Peptide having apoptosis-inhibiting activity |
| 04/05/2006 | EP1642899A1 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same |
| 04/05/2006 | EP1642898A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642593A1 Solid pharmaceutical preparation |
| 04/05/2006 | EP1642583A2 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1641824A1 Relaxin superfamily peptide analogues |
| 04/05/2006 | EP1641823A2 Glp-1 analog fusion plroteins |
| 04/05/2006 | EP1641799A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 04/05/2006 | EP1641794A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 04/05/2006 | EP1641792A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 04/05/2006 | EP1641791A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
| 04/05/2006 | EP1641789A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641763A2 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 04/05/2006 | EP1641755A1 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (gcs) inhibitor |
| 04/05/2006 | EP1641483A2 Fusion proteins |
| 04/05/2006 | EP1641475A1 Lipids from methanotrophic bacteria for cholesterol reduction |
| 04/05/2006 | EP1641467A1 (20s)-1alpha-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
| 04/05/2006 | EP1641466A1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1435235B1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/05/2006 | EP1411960B1 Fortified rice bran food product for promoting cardiovascular health |
| 04/05/2006 | EP1409494B1 Stabilized derivatives of ascorbic acid -3- phosphate |
| 04/05/2006 | EP1409102B1 Method and installation for setting in adsorbed state on a porous support active compounds contained in a product |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1235581B1 Use of ribose to prevent cramping and soreness in muscles |
| 04/05/2006 | EP1147413B1 Growth differentiation factor inhibitors and uses therefor |
| 04/05/2006 | EP1094824B1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | EP0981514B1 3-epi vitamin d2 compounds and uses thereof |
| 04/05/2006 | EP0965339B1 Tabletted nateglinide preparation |
| 04/05/2006 | EP0800397B1 Bone mass anabolic composition comprising olpadronate |
| 04/05/2006 | CN1756842A Branched neutral amino acid transporters acting as single molecule |
| 04/05/2006 | CN1756756A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756755A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756752A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756750A Adiponectin expression promoter |
| 04/05/2006 | CN1756748A 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1756741A Lipid metabolism improving agent |
| 04/05/2006 | CN1756567A Body weight gain inhibitor |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1756545A Use of omega-3-fatty acids in the treatment of diabetic patients |
| 04/05/2006 | CN1754575A Oral insulin protecting agent |
| 04/05/2006 | CN1754556A Compound kudzu root and glibenclamide pharmaceutical composition and its preparation method |
| 04/05/2006 | CN1754546A Traditional Chinese medicine formulation for treating and preventing diabetes and its angiopathy |
| 04/05/2006 | CN1754545A Use of plant lactobacillus ST-III in fat-reduction |
| 04/05/2006 | CN1754541A Steroid saponin pharmaceutical composition and its preparation method and uses |
| 04/05/2006 | CN1754534A Lysine hydrochlorate for injection and its preparation method |
| 04/05/2006 | CN1249091C Fibre containing composition for enteral nutrition |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/05/2006 | CN1249024C Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 04/05/2006 | CN1248686C Application of 5-amino-levulinic acid in swine growth promoters |
| 04/05/2006 | CN1248683C Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1248597C 林蛙油软胶囊 Rana oil capsules |
| 04/04/2006 | USRE39055 Hepatoselective pharmaceutical actives |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022732 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022725 Isoxazole derivatives |
| 04/04/2006 | US7022723 Heterocyclic compounds |